Cargando…

Prodigiosin: a promising biomolecule with many potential biomedical applications

Pigments are among the most fascinating molecules found in nature and used by human civilizations since the prehistoric ages. Although most of the bio-dyes reported in the literature were discovered around the eighties, the necessity to explore novel compounds for new biological applications has mad...

Descripción completa

Detalles Bibliográficos
Autores principales: Islan, German A., Rodenak-Kladniew, Boris, Noacco, Nehuen, Duran, Nelson, Castro, Guillermo R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342244/
https://www.ncbi.nlm.nih.gov/pubmed/35734783
http://dx.doi.org/10.1080/21655979.2022.2084498
_version_ 1784760782499610624
author Islan, German A.
Rodenak-Kladniew, Boris
Noacco, Nehuen
Duran, Nelson
Castro, Guillermo R.
author_facet Islan, German A.
Rodenak-Kladniew, Boris
Noacco, Nehuen
Duran, Nelson
Castro, Guillermo R.
author_sort Islan, German A.
collection PubMed
description Pigments are among the most fascinating molecules found in nature and used by human civilizations since the prehistoric ages. Although most of the bio-dyes reported in the literature were discovered around the eighties, the necessity to explore novel compounds for new biological applications has made them resurface as potential alternatives. Prodigiosin (PG) is an alkaloid red bio-dye produced by diverse microorganisms and composed of a linear tripyrrole chemical structure. PG emerges as a really interesting tool since it shows a wide spectrum of biological activities, such as antibacterial, antifungal, algicidal, anti-Chagas, anti-amoebic, antimalarial, anticancer, antiparasitic, antiviral, and/or immunosuppressive. However, PG vehiculation into different delivery systems has been proposed since possesses low bioavailability because of its high hydrophobic character (XLogP3-AA = 4.5). In the present review, the general aspects of the PG correlated with synthesis, production process, and biological activities are reported. Besides, some of the most relevant PG delivery systems described in the literature, as well as novel unexplored applications to potentiate its biological activity in biomedical applications, are proposed.
format Online
Article
Text
id pubmed-9342244
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-93422442022-08-02 Prodigiosin: a promising biomolecule with many potential biomedical applications Islan, German A. Rodenak-Kladniew, Boris Noacco, Nehuen Duran, Nelson Castro, Guillermo R. Bioengineered Review Pigments are among the most fascinating molecules found in nature and used by human civilizations since the prehistoric ages. Although most of the bio-dyes reported in the literature were discovered around the eighties, the necessity to explore novel compounds for new biological applications has made them resurface as potential alternatives. Prodigiosin (PG) is an alkaloid red bio-dye produced by diverse microorganisms and composed of a linear tripyrrole chemical structure. PG emerges as a really interesting tool since it shows a wide spectrum of biological activities, such as antibacterial, antifungal, algicidal, anti-Chagas, anti-amoebic, antimalarial, anticancer, antiparasitic, antiviral, and/or immunosuppressive. However, PG vehiculation into different delivery systems has been proposed since possesses low bioavailability because of its high hydrophobic character (XLogP3-AA = 4.5). In the present review, the general aspects of the PG correlated with synthesis, production process, and biological activities are reported. Besides, some of the most relevant PG delivery systems described in the literature, as well as novel unexplored applications to potentiate its biological activity in biomedical applications, are proposed. Taylor & Francis 2022-06-22 /pmc/articles/PMC9342244/ /pubmed/35734783 http://dx.doi.org/10.1080/21655979.2022.2084498 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Islan, German A.
Rodenak-Kladniew, Boris
Noacco, Nehuen
Duran, Nelson
Castro, Guillermo R.
Prodigiosin: a promising biomolecule with many potential biomedical applications
title Prodigiosin: a promising biomolecule with many potential biomedical applications
title_full Prodigiosin: a promising biomolecule with many potential biomedical applications
title_fullStr Prodigiosin: a promising biomolecule with many potential biomedical applications
title_full_unstemmed Prodigiosin: a promising biomolecule with many potential biomedical applications
title_short Prodigiosin: a promising biomolecule with many potential biomedical applications
title_sort prodigiosin: a promising biomolecule with many potential biomedical applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342244/
https://www.ncbi.nlm.nih.gov/pubmed/35734783
http://dx.doi.org/10.1080/21655979.2022.2084498
work_keys_str_mv AT islangermana prodigiosinapromisingbiomoleculewithmanypotentialbiomedicalapplications
AT rodenakkladniewboris prodigiosinapromisingbiomoleculewithmanypotentialbiomedicalapplications
AT noacconehuen prodigiosinapromisingbiomoleculewithmanypotentialbiomedicalapplications
AT durannelson prodigiosinapromisingbiomoleculewithmanypotentialbiomedicalapplications
AT castroguillermor prodigiosinapromisingbiomoleculewithmanypotentialbiomedicalapplications